IONS Ionis Pharmaceuticals, Inc. - Common Stock
$58,28
Cena · Sie 18, 2026
Dane fundamentalne na dzień Lip 29, 2026
Zakres 52 tyg.
$42–$87
37% of range
Ocena Analityków
BUY
31 analysts
Cena Docelowa
$89
+53% upside
P/E (TTM)
-24.5
ROE
-68.1%
Marża Zysku Netto
—
IONS Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
Cena
$58.28
Kapitalizacja Rynkowa
$9.52B
P/E (TTM)
-24.5
EPS (TTM)
$-2.38
Przychody (TTM)
—
Stopa dywidendy
—
ROE
-68.1%
D/E Dług/Kapitał
3.6
Zakres 52 tyg.
$42 – $87
IONS Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
Configure
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Przychody i Zysk Netto
—
2016-12-31
→
2017-12-31
EPS
$-2.38
2016-12-31
→
2025-12-31
Wolny przepływ pieniężny
$-320M
2016-12-31
→
2025-12-31
Marże
—
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
Wskaźnik
Trend 5-letni
IONS
Mediana porównawcza
P/E (TTM)
-24.5
16.0
P/S (TTM)
10.1
32.5
P/B
19.5
3.9
EV / EBITDA
-22.5
—
Price / FCF (Cena / FCF)
-29.7
—
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
Wskaźnik
Trend 5-letni
IONS
Mediana porównawcza
ROA
-11.7%
-22.2%
ROE
-68.1%
-37.6%
ROIC
-17.1%
—
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
Wskaźnik
Trend 5-letni
IONS
Mediana porównawcza
Debt / Equity (Dług / Kapitał Własny)
3.6
0.0
Current Ratio (Wskaźnik bieżący)
3.8
5.7
Quick Ratio (Wskaźnik Szybkości)
3.4
—
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
Wskaźnik
Trend 5-letni
IONS
Mediana porównawcza
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
Wskaźnik
Trend 5-letni
IONS
Mediana porównawcza
IONS Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
KUP
31 analityków
- Mocne kupno 8 25,8%
- Kup 17 54,8%
- Trzymaj 6 19,4%
- Sprzedaj 0 0,0%
- Mocna sprzedaż 0 0,0%
12-miesięczny cel cenowy
21 analityków · 2026-08-18
Mediana
$90.00
← Poniżej wszystkich celów
$58.28
Niski
$66.00
Wysoki
$115.00
Średni cel
$90.00
+54,4%
Średnia cel
$89.33
+53,3%
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
Średnie zaskoczenie
0.42%
| Okres | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|
| 30 czerwca 2026 | $-0.69 | $-1.09 | 0.40% |
| 31 marca 2026 | $-0.56 | $-0.93 | 0.37% |
| 31 grudnia 2025 | $-1.41 | $-1.35 | -0.06% |
| 30 września 2025 | $-0.80 | $-1.26 | 0.46% |
| 30 czerwca 2025 | $0.70 | $-0.44 | 1.1% |
| 31 marca 2025 | $-0.93 | $-1.14 | 0.21% |
Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| IONS | $12.92B | -33.2 | — | — | -68.1% | — |
| APGE | $5.16B | -17.9 | — | — | — | — |
| PTGX | $5.47B | -42.6 | -89.4% | -282.8% | -20.3% | — |
| KYMR | $6.33B | -21.1 | -16.7% | -794.0% | -24.4% | — |
| KRYS | $7.20B | 36.0 | 33.9% | 52.6% | 18.1% | — |
| SYRE | $2.56B | 10.1 | -62.0% | — | -26.5% | — |
| PCVX | $6.05B | -8.2 | — | — | -26.6% | — |
| IMVT | $5.07B | -9.0 | 229.2% | — | -73.7% | — |
| IBRX | $2.00B | -5.2 | 668.3% | -310.2% | 71.0% | — |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat 16
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | · | · | · | $508M | $347M | $284M | $214M | |
| Cost of Revenue | $16M | $11M | $9M | $14M | $11M | $12M | $4M | $2M | $0 | $0 | · | · | |
| R&D Expense | $916M | $902M | $900M | · | $638M | $531M | $462M | $412M | $372M | $340M | $320M | $239M | |
| SG&A Expense | $394M | $267M | $233M | $150M | $186M | $354M | $287M | $245M | $108M | $49M | $37M | $20M | |
| Operating Expenses | $1.33B | $1.18B | $1.14B | $998M | $841M | $901M | $757M | $661M | $483M | $393M | $359M | $262M | |
| Operating Income | $-382M | $-475M | $-354M | $-410M | $-30M | $-172M | $366M | $-61M | $31M | $-20M | $-76M | $-48M | |
| Interest Expense | $17M | $17M | $13M | $8M | $9M | $10M | $12M | $45M | $45M | $39M | $37M | $22M | |
| Other Non-op | $-15M | $1M | $14M | $-7M | $-10M | $-62.0K | $-686.0K | $-182.0K | $-4M | $0 | · | · | |
| Pretax Income | $-380M | $-460M | $-334M | $-258M | $-29M | $-135M | $339M | $-76M | $-17M | $-57M | $-88M | $-54M | |
| Income Tax | $2M | $-6M | $32M | $12M | $-551.0K | $345M | $52M | $-291M | $-6M | $3M | $372.0K | $-15M | |
| Net Income | $-381M | $-454M | $-366M | $-270M | $-29M | $-444M | $278M | $274M | $346.0K | $-60M | $-88M | $-39M | |
| EPS (Basic) | $-2.38 | $-3.04 | $-2.56 | $-1.90 | $-0.20 | $-3.18 | $2.00 | $2.09 | $0.15 | $-0.50 | $-0.74 | · | |
| EPS (Diluted) | $-2.38 | $-3.04 | $-2.56 | $-1.90 | $-0.20 | $-3.18 | $1.90 | $2.07 | $0.15 | $-0.50 | $-0.74 | · | |
| Shares (Basic) | 160,010,000 | 149,514,000 | 143,190,000 | 141,848,000 | 141,021,000 | 139,612,000 | 139,998,000 | 132,320,000 | 124,016,000 | 120,933,000 | 119,719,000 | · | |
| Shares (Diluted) | 160,010,000 | 149,514,000 | 143,190,000 | 141,848,000 | 141,021,000 | 139,612,000 | 153,164,000 | 134,056,000 | 126,098,000 | 120,933,000 | 119,719,000 | · | |
| EBITDA | $-382M | $-475M | $-354M | $-410M | $-30M | $-172M | $366M | $-61M | $25M | $-46M | $-76M | $-48M |
Bilans 24
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $372M | $242M | $399M | $276M | $869M | $398M | $683M | $279M | $130M | $85M | $129M | $143M | |
| Short-term Investments | $2.31B | $2.06B | $1.93B | $1.71B | $1.25B | · | · | · | · | · | · | · | |
| Inventory | $10M | $13M | $7M | $22M | $25M | $22M | $18M | $9M | $10M | · | · | · | |
| Other Current Assets | $237M | $218M | $205M | $168M | $143M | $140M | $140M | $102M | $73M | $17M | $15M | $16M | |
| Current Assets | $2.99B | $2.62B | $2.64B | $2.20B | $2.35B | $2.13B | $2.72B | $2.21B | $1.17B | $798M | $837M | $837M | |
| PP&E (Net) | $123M | $94M | $71M | $74M | $178M | $181M | $154M | $132M | $122M | $93M | $90M | $89M | |
| Accum. Depreciation | $109M | $106M | $97M | $88M | $103M | $87M | $74M | $61M | $88M | $80M | $73M | $66M | |
| Intangibles | · | · | · | · | $29M | $28M | $26M | $24M | $22M | $20M | · | · | |
| Other Non-current Assets | $172M | $127M | $105M | $75M | $71M | $50M | $28M | $13M | $10M | $1M | · | · | |
| Total Assets | $3.52B | $3.00B | $2.99B | $2.53B | $2.61B | $2.39B | $3.23B | $2.67B | $1.32B | $912M | $948M | $956M | |
| Accounts Payable | $28M | $43M | $26M | $18M | $12M | $17M | $16M | $29M | $25M | $21M | $28M | $18M | |
| Accrued Liabilities | $106M | $108M | $148M | $140M | $89M | $90M | $67M | $48M | $67M | $36M | $28M | $30M | |
| Current Liabilities | $782M | $309M | $448M | $312M | $241M | $599M | $273M | $280M | $244M | $134M | $149M | $115M | |
| Capital Leases | $262M | $162M | $171M | $179M | $19M | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | $28M | $52M | $42M | $16M | $7M | · | · | · | · | · | · | · | |
| Total Liabilities | $3.03B | $2.42B | $2.60B | $1.96B | $1.84B | $1.65B | $1.55B | $1.48B | $957M | $813M | $747M | $698M | |
| Long-term Debt | $1.81B | $1.25B | $1.31B | $1.19B | · | · | · | · | · | · | · | · | |
| Total Debt | $1.76B | $1.20B | $1.24B | $1.18B | · | · | · | · | · | · | · | · | |
| Common Stock | $163.0K | $158.0K | $144.0K | $142.0K | $141.0K | $140.0K | $140.0K | $138.0K | $125.0K | $122.0K | $120.0K | $118.0K | |
| Retained Earnings | $-2.63B | $-2.25B | $-1.80B | $-1.43B | $-1.16B | $-1.13B | $-708M | $-967M | $-1.24B | $-1.18B | $-1.09B | $-1.01B | |
| AOCI | $-25M | $-31M | $-33M | $-57M | $-33M | $-21M | $-25M | $-32M | $-32M | $-30M | $-14M | $40M | |
| Stockholders' Equity | $489M | $588M | $387M | $573M | $772M | $743M | $1.47B | $1.05B | $281M | $100M | $201M | $258M | |
| Liabilities + Equity | $3.52B | $3.00B | $2.99B | $2.53B | $2.61B | $2.39B | $3.23B | $2.67B | $1.32B | $912M | $948M | $956M | |
| Shares Outstanding | 163,304,875 | 157,908,815 | 144,340,526 | 142,057,736 | 141,210,015 | 140,365,594 | 140,339,615 | 137,928,828 | 124,976,373 | 121,636,273 | 120,351,480 | 118,442,726 |
Przepływy pieniężne 14
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $134M | $130M | $106M | $100M | $121M | $230M | $147M | $131M | $86M | $72M | $59M | $31M | |
| Deferred Tax | $0 | $0 | $0 | $0 | $0 | $342M | $904.0K | $-291M | $0 | $0 | $0 | $-11M | |
| Amort. of Intangibles | $2M | $2M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | · | · | |
| Operating Cash Flow | $-269M | $-501M | $-308M | $-274M | $31M | $36M | $346M | $603M | $174M | $-112M | $21M | $6M | |
| CapEx | $51M | $45M | $24M | $16M | $12M | $35M | $31M | $14M | $35M | $7M | $8M | $8M | |
| Investing Cash Flow | $-278M | $-134M | $-214M | $-263M | $195M | $274M | $-41M | $-930M | $-358M | $57M | $-60M | · | |
| Stock Issued | $0 | $489M | $0 | $0 | · | $0 | $0 | $448M | $72M | $0 | $0 | $0 | |
| Stock Repurchased | · | · | · | $0 | $0 | $91M | $34M | $0 | $0 | · | · | · | |
| Net Stock Activity | $0 | $489M | · | $0 | $0 | $-91M | $-34M | · | $72M | · | $0 | $0 | |
| Financing Cash Flow | $676M | $478M | $644M | $-55M | $246M | $-597M | $100M | $476M | $229M | $11M | $25M | · | |
| Net Change in Cash | $130M | $-157M | $123M | $-593M | $472M | $-286M | $404M | $149M | $45M | $-44M | $-14M | · | |
| Taxes Paid | $-639.0K | $-6M | $48M | $5M | · | $26M | $9M | $0 | $0 | · | · | · | |
| Free Cash Flow | $-320M | $-546M | $-331M | $-290M | $19M | $772.0K | $315M | $589M | $139M | $-119M | $13M | $-1M | |
| Levered FCF | $-337M | $-563M | $-345M | $-299M | $10M | $-128M | $272M | $716M | $106M | $-159M | $-23M | $-17M |
Rentowność 7
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | · | · | · | 4.8% | -13.4% | -26.7% | -22.3% | |
| Net Margin | · | · | · | · | · | · | · | · | -1.2% | -25.0% | -31.1% | -18.2% | |
| Pretax Margin | · | · | · | · | · | · | · | · | -4.6% | -24.1% | -31.0% | -25.4% | |
| EBITDA Margin | · | · | · | · | · | · | · | · | 4.8% | -13.4% | -26.7% | -22.3% | |
| ROA | -11.7% | -15.2% | -13.3% | -10.5% | -1.1% | -16.1% | 10.0% | 13.7% | -0.53% | -9.3% | -9.2% | -4.3% | |
| ROE | -68.1% | -71.9% | -104.3% | -40.1% | -3.8% | -39.0% | 23.4% | 41.2% | -2.8% | -57.6% | -38.5% | -12.3% | |
| ROIC | -17.1% | -26.0% | -23.8% | -24.5% | -3.8% | -58.4% | 21.8% | 16.5% | 5.5% | -48.1% | -37.9% | -13.3% |
Płynność i wypłacalność 5
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.8 | 8.5 | 5.9 | 7.1 | 9.7 | 3.7 | 10.0 | 7.9 | 5.2 | 6.0 | 5.6 | 7.3 | |
| Quick Ratio | 3.4 | 7.4 | 5.2 | 6.4 | 3.6 | 0.7 | 2.5 | 1.0 | 0.6 | 0.6 | 0.9 | 1.2 | |
| Debt / Equity | 3.6 | 2.0 | 3.2 | 2.1 | · | · | · | · | · | · | · | · | |
| LT Debt / Equity | 2.7 | 2.0 | 3.2 | 2.1 | · | · | · | · | · | · | · | · | |
| Interest Coverage | -22.1 | -28.0 | -27.9 | -50.5 | -3.2 | -3.8 | 7.5 | -1.4 | 0.5 | -1.2 | -2.1 | -2.1 |
Efektywność 2
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | · | · | · | 0.5 | 0.4 | 0.3 | 0.2 | |
| Inventory Turnover | 1.4 | 1.1 | 0.4 | 0.6 | 0.5 | 0.6 | 0.3 | 0.2 | · | · | · | · |
Wycena (TTM) 14
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $944M | $705M | $788M | $587M | $810M | $729M | $1.12B | $600M | $508M | $347M | $284M | $214M | |
| Net Income TTM | $-381M | $-454M | $-366M | $-270M | $-29M | $-444M | $278M | $274M | $346.0K | $-60M | $-88M | $-39M | |
| Market Cap | $12.92B | $5.52B | $7.30B | $5.37B | $4.30B | $7.94B | $8.48B | $7.46B | $6.29B | $5.82B | $7.45B | $7.31B | |
| Enterprise Value | $12.00B | $4.43B | $6.21B | $4.55B | · | · | · | · | · | · | · | · | |
| P/E | -33.2 | -11.5 | -19.8 | -19.9 | -152.2 | -17.8 | 31.8 | 26.1 | 335.3 | -95.7 | -83.7 | -176.4 | |
| P/S | 13.7 | 7.8 | 9.3 | 9.1 | 5.3 | 10.9 | 7.6 | 12.4 | 12.4 | 16.8 | 26.3 | 34.1 | |
| P/B | 26.4 | 9.2 | 18.9 | 9.4 | 5.6 | 9.4 | 5.8 | 7.1 | 19.0 | 58.4 | 37.1 | 28.4 | |
| P / Tangible Book | 26.4 | 9.4 | 18.9 | 9.4 | 5.8 | 11.1 | · | · | · | · | · | · | |
| P / Cash Flow | -48.1 | -11.0 | -23.7 | -19.6 | 139.5 | 221.1 | 24.5 | 12.4 | 36.1 | -51.9 | 352.8 | 1163.5 | |
| P / FCF | -40.4 | -10.1 | -22.0 | -18.5 | 228.0 | 10280.1 | 26.9 | 12.7 | 45.1 | -48.8 | 554.9 | -5930.8 | |
| EV / EBITDA | -31.4 | -9.3 | -17.6 | -11.1 | · | · | · | · | · | · | · | · | |
| EV / FCF | -37.5 | -8.1 | -18.7 | -15.7 | · | · | · | · | · | · | · | · | |
| EV / Revenue | 12.7 | 6.3 | 7.9 | 7.8 | · | · | · | · | · | · | · | · | |
| Earnings Yield | -3.0% | -8.7% | -5.1% | -5.0% | -0.66% | -5.6% | 3.1% | 3.8% | 0.30% | -1.1% | -1.2% | -0.57% |
Rachunek zysków i strat 15
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $268M | $246M | $203M | $157M | $452M | $132M | $227M | $134M | $225M | $119M | $325M | $144M | $188M | $131M | $152M | $160M | |
| Cost of Revenue | $3M | $3M | $8M | $2M | $4M | $1M | $4M | $1M | $4M | $2M | $3M | $2M | $3M | $1M | $4M | $2M | |
| SG&A Expense | $150M | $150M | $130M | $97M | $91M | $76M | $88M | $62M | $65M | $53M | $71M | $70M | $46M | $46M | $48M | $34M | |
| Operating Expenses | $370M | $364M | $418M | $317M | $312M | $278M | $337M | $282M | $291M | $269M | $331M | $287M | $279M | $245M | $360M | $219M | |
| Operating Income | $-102M | $-117M | $-214M | $-160M | $140M | $-147M | $-111M | $-149M | $-66M | $-150M | $-6M | $-143M | $-90M | $-114M | $-208M | $-59M | |
| Interest Expense | $5M | $5M | $5M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $5M | $4M | $2M | $2M | $2M | $2M | |
| Other Non-op | $987.0K | $-456.0K | $-16M | $363.0K | $102.0K | $465.0K | $302.0K | $142.0K | $610.0K | $277.0K | $235.0K | $2M | $11M | $230.0K | $123.0K | $5M | |
| Pretax Income | $-113M | $-92M | $-228M | $-128M | $124M | $-147M | $-107M | $-144M | $-66M | $-143M | $-3M | $-141M | $-77M | $-113M | $-44M | $-47M | |
| Income Tax | $1M | $218.0K | $1M | $213.0K | $-20.0K | $116.0K | $-3M | $-4M | $64.0K | $75.0K | $6M | $7M | $8M | $11M | $8M | $283.0K | |
| Net Income | $-115M | $-93M | $-229M | $-129M | $124M | $-147M | $-104M | $-140M | $-66M | $-143M | $-9M | $-147M | $-85M | $-124M | $-52M | $-47M | |
| EPS (Basic) | $-0.69 | $-0.56 | $-1.41 | $-0.80 | $0.78 | $-0.93 | $-0.66 | $-0.95 | $-0.45 | $-0.98 | $-0.06 | $-1.03 | $-0.60 | $-0.87 | $-0.37 | $-0.33 | |
| EPS (Diluted) | $-0.69 | $-0.56 | $-1.41 | $-0.80 | $0.70 | $-0.93 | $-0.66 | $-0.95 | $-0.45 | $-0.98 | $-0.06 | $-1.03 | $-0.60 | $-0.87 | $-0.37 | $-0.33 | |
| Shares (Basic) | 165,419,000 | 164,874,000 | -317,627,000 | 159,765,000 | 159,137,000 | 158,735,000 | -290,575,000 | 148,593,000 | 145,958,000 | 145,538,000 | -285,960,000 | 143,317,000 | 143,098,000 | 142,735,000 | -283,495,000 | 141,950,000 | |
| Shares (Diluted) | 165,419,000 | 164,874,000 | -340,821,000 | 159,765,000 | 182,331,000 | 158,735,000 | -290,575,000 | 148,593,000 | 145,958,000 | 145,538,000 | -285,960,000 | 143,317,000 | 143,098,000 | 142,735,000 | -283,495,000 | 141,950,000 | |
| EBITDA | $-102M | $-117M | · | $-160M | $140M | $-147M | · | $-149M | $-66M | $-150M | · | $-143M | $-90M | $-114M | · | $-59M |
Bilans 23
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $350M | $173M | $372M | $338M | $297M | $264M | $242M | $335M | $294M | $349M | · | $352M | $425M | $309M | · | $315M | |
| Short-term Investments | $1.70B | $1.75B | $2.31B | $1.90B | $1.99B | $1.88B | $2.06B | $2.15B | $1.78B | $1.86B | · | $1.88B | $1.96B | $2.04B | · | $1.67B | |
| Inventory | $51M | $6M | $10M | $10M | $8M | $12M | $13M | $28M | $29M | $30M | · | $26M | $26M | $22M | · | $21M | |
| Other Current Assets | $327M | $306M | $237M | $244M | $226M | $223M | $218M | $184M | $195M | $174M | · | $181M | $178M | $160M | · | $143M | |
| Current Assets | $2.49B | $2.94B | $2.99B | $2.52B | $2.58B | $2.42B | $2.62B | $2.71B | $2.33B | $2.42B | · | $2.58B | $2.62B | $2.54B | · | $2.15B | |
| PP&E (Net) | $155M | $142M | $123M | $106M | $112M | $103M | $94M | $83M | $76M | $73M | · | $71M | $92M | $85M | · | $181M | |
| Accum. Depreciation | · | · | $109M | · | · | · | $106M | · | · | · | · | · | · | · | · | · | |
| Intangibles | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $30M | |
| Other Non-current Assets | $117M | $136M | $172M | $166M | $132M | $132M | $127M | $120M | $119M | $106M | · | $104M | $86M | $78M | · | $59M | |
| Total Assets | $2.99B | $3.45B | $3.52B | $3.03B | $2.99B | $2.81B | $3.00B | $3.08B | $2.69B | $2.76B | · | $2.93B | $2.97B | $2.89B | · | $2.42B | |
| Accounts Payable | $48M | $26M | $28M | $14M | $23M | $17M | $43M | $9M | $9M | $13M | · | $6M | $24M | $10M | · | $21M | |
| Accrued Liabilities | $116M | $127M | $106M | $99M | $99M | $103M | $108M | $124M | $114M | $106M | · | $119M | $105M | $113M | · | $128M | |
| Current Liabilities | $316M | $717M | $782M | $903M | $897M | $250M | $309M | $305M | $306M | $328M | · | $404M | $288M | $259M | · | $283M | |
| Capital Leases | $262M | $259M | $262M | $263M | $164M | $159M | $162M | $168M | $166M | $169M | · | $173M | $175M | $177M | · | · | |
| Other Non-current Liabilities | $28M | $28M | · | $29M | $59M | $56M | · | $42M | $42M | $42M | · | $49M | $16M | $7M | · | · | |
| Total Liabilities | $2.55B | $2.96B | $3.03B | $2.42B | $2.35B | $2.34B | $2.42B | $2.42B | $2.43B | $2.47B | · | $2.62B | $2.54B | $2.40B | · | $1.83B | |
| Long-term Debt | · | · | $1.81B | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Common Stock | $166.0K | $166.0K | $163.0K | $161.0K | $159.0K | $159.0K | $158.0K | $158.0K | $146.0K | $146.0K | · | $143.0K | $143.0K | $143.0K | · | $142.0K | |
| Retained Earnings | $-2.84B | $-2.72B | $-2.63B | $-2.40B | $-2.27B | $-2.40B | $-2.25B | $-2.15B | $-2.00B | $-1.94B | · | $-1.79B | $-1.64B | $-1.55B | · | $-1.38B | |
| AOCI | $-34M | $-31M | $-25M | $-26M | $-28M | $-29M | $-31M | $-24M | $-35M | $-35M | · | $-46M | $-51M | $-49M | · | $-63M | |
| Stockholders' Equity | $440M | $491M | $489M | $618M | $632M | $476M | $588M | $662M | $264M | $297M | $387M | $315M | $428M | $487M | $573M | $594M | |
| Liabilities + Equity | $2.99B | $3.45B | $3.52B | $3.03B | $2.99B | $2.81B | $3.00B | $3.08B | $2.69B | $2.76B | · | $2.93B | $2.97B | $2.89B | · | $2.42B | |
| Shares Outstanding | 165,636,792 | 165,902,064 | 163,304,875 | 161,137,930 | 159,196,782 | 159,041,259 | 157,908,815 | 157,813,136 | 146,025,246 | 145,844,719 | · | 143,393,493 | 143,167,414 | 143,022,539 | · | 142,017,411 |
Przepływy pieniężne 11
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $46M | $43M | $43M | $31M | $30M | $30M | $36M | $32M | $31M | $31M | $26M | $26M | $27M | $27M | $26M | $24M | |
| Amort. of Intangibles | $700.0K | $661.0K | $638.0K | $621.0K | $598.0K | $582.0K | $459.0K | $617.0K | $621.0K | $639.0K | $655.0K | $660.0K | $637.0K | $607.0K | $610.0K | $608.0K | |
| Operating Cash Flow | $566M | $-793M | $-138M | $-131M | $151M | $-151M | $-116M | $-115M | $-120M | $-150M | $33M | $-109M | $-97M | $-134M | $-200M | $-24M | |
| CapEx | $16M | $22M | $21M | $5M | $12M | $13M | $25M | $9M | $6M | $4M | $-819.0K | $2M | $12M | $10M | $4M | $6M | |
| Investing Cash Flow | $23M | $537M | $-420M | $91M | $-120M | $170M | $68M | $-341M | $62M | $76M | $-27M | $69M | $70M | $-326M | $212M | $-184M | |
| Stock Issued | · | · | $0 | · | · | · | $27.0K | · | · | · | $0 | · | · | · | · | · | |
| Financing Cash Flow | $-412M | $57M | $591M | $81M | $1M | $2M | $-44M | $496M | $3M | $24M | $41M | $-32M | $144M | $492M | $-51M | $2M | |
| Net Change in Cash | $177M | $-199M | $34M | $41M | $33M | $22M | $-93M | $41M | $-55M | $-50M | $47M | $-73M | $116M | $33M | $-39M | $-207M | |
| Taxes Paid | $1M | $-8.0K | $22.0K | $-278.0K | $17.0K | $-400.0K | $-8M | $80.0K | $2M | $13.0K | · | · | · | · | · | · | |
| Free Cash Flow | · | $-815M | · | · | · | $-163M | · | · | · | $-154M | · | · | · | $-144M | · | · | |
| Levered FCF | · | $-820M | · | · | · | $-167M | · | · | · | $-159M | · | · | · | $-146M | · | · |
Rentowność 7
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -38.2% | -47.7% | · | -102.2% | 30.9% | -111.6% | · | -111.1% | -29.3% | -125.1% | · | -99.4% | -47.9% | -87.5% | · | -37.0% | |
| Net Margin | -42.8% | -37.6% | · | -82.1% | 27.3% | -111.6% | · | -105.0% | -29.4% | -119.5% | · | -102.2% | -45.3% | -95.2% | · | -29.4% | |
| Pretax Margin | -42.3% | -37.5% | · | -81.9% | 27.3% | -111.6% | · | -107.7% | -29.4% | -119.4% | · | -97.6% | -41.1% | -86.5% | · | -29.2% | |
| EBITDA Margin | -38.2% | -47.7% | · | -102.2% | 30.9% | -111.6% | · | -111.1% | -29.3% | -125.1% | · | -99.4% | -47.9% | -87.5% | · | -37.0% | |
| ROA | -3.8% | -2.9% | · | -4.2% | 4.3% | -5.3% | · | -4.7% | -2.3% | -5.1% | · | -5.5% | -3.1% | -4.6% | · | -1.9% | |
| ROE | -21.4% | -19.1% | · | -20.1% | 27.6% | -38.0% | · | -28.7% | -19.1% | -36.5% | · | -32.4% | -16.2% | -20.8% | · | -8.3% | |
| ROIC | -23.5% | -23.9% | · | -26.0% | 22.1% | -30.9% | · | -21.9% | -25.1% | -50.4% | · | -47.5% | -23.2% | -25.8% | · | -10.0% |
Płynność i wypłacalność 3
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 7.9 | 4.1 | · | 2.8 | 2.9 | 9.7 | · | 8.9 | 7.6 | 7.4 | · | 6.4 | 9.1 | 9.8 | · | 7.6 | |
| Quick Ratio | 6.5 | 2.7 | · | 2.5 | 2.6 | 8.6 | · | 8.2 | 6.8 | 6.7 | · | 5.5 | 8.3 | 9.1 | · | 7.0 | |
| Interest Coverage | -22.2 | -22.8 | · | -38.0 | 34.0 | -35.7 | · | -35.7 | -14.7 | -36.0 | · | -34.1 | -39.4 | -71.0 | · | -27.7 |
Efektywność 2
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.2 | 0.0 | · | 0.0 | 0.1 | 0.0 | · | 0.1 | 0.1 | 0.0 | · | 0.1 | |
| Inventory Turnover | 0.1 | 0.3 | · | 0.1 | 0.2 | 0.1 | · | 0.0 | 0.2 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 |
Wycena (TTM) 10
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $874M | $1.06B | · | $967M | $944M | $717M | · | $803M | $813M | $777M | · | $615M | $631M | $576M | · | $875M | |
| Net Income TTM | $-565M | $-327M | · | $-256M | $-268M | $-458M | · | $-359M | $-366M | $-385M | · | $-409M | $-309M | $-329M | · | $7M | |
| Market Cap | $13.13B | $12.46B | · | $10.54B | $6.29B | $4.80B | · | $6.32B | $6.96B | $6.32B | · | $6.50B | $5.87B | $5.11B | · | $6.28B | |
| P/E | -22.9 | -36.3 | · | -38.7 | -21.5 | -10.1 | · | -16.4 | -18.9 | -16.2 | · | -15.8 | -18.9 | -15.5 | · | -368.6 | |
| P/S | 15.0 | 11.8 | · | 10.9 | 6.7 | 6.7 | · | 7.9 | 8.6 | 8.1 | · | 10.6 | 9.3 | 8.9 | · | 7.2 | |
| P/B | 29.9 | 25.4 | · | 17.1 | 10.0 | 10.1 | · | 9.5 | 26.4 | 21.3 | · | 20.6 | 13.7 | 10.5 | · | 10.6 | |
| P / Tangible Book | 29.9 | 25.4 | · | 17.1 | 10.0 | 10.1 | · | 9.5 | 26.4 | 21.3 | · | 20.6 | 13.7 | 10.5 | · | 11.1 | |
| P / Cash Flow | · | -15.7 | · | · | · | -31.8 | · | · | · | -42.2 | · | · | · | -38.1 | · | · | |
| P / FCF | · | -15.3 | · | · | · | -29.4 | · | · | · | -40.9 | · | · | · | -35.4 | · | · | |
| Earnings Yield | -4.4% | -2.8% | · | -2.6% | -4.7% | -9.9% | · | -6.1% | -5.3% | -6.2% | · | -6.3% | -5.3% | -6.5% | · | -0.27% |
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
Rachunek zysków i strat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Zysk netto | $-381M | $-454M | $-366M | $-270M | $-29M |
| Rozwodniony EPS | $-2.38 | $-3.04 | $-2.56 | $-1.90 | $-0.20 |
Bilans
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Dług / Kapitał Własny | 3.6 | 2.0 | 3.2 | 2.1 | — |
| Wskaźnik bieżący | 3.8 | 8.5 | 5.9 | 7.1 | 9.7 |
| Wskaźnik Szybkości | 3.4 | 7.4 | 5.2 | 6.4 | 3.6 |
Przepływy pieniężne
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | $-320M | $-546M | $-331M | $-290M | $19M |
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
📊
Wybierz metryki, które są dla Ciebie ważne — kliknij ➕ obok dowolnego wiersza w Pełnych Fundamentach powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.
Właściciele instytucjonalni (13F) 575 emitentów · $10.8B łącznie · Na dzień 30 czerwca 2026
Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.
Aktywność instytucjonalna — Q2 2026 vs poprzedni kwartał
| Nowe pozycje | Zamknięte pozycje | Zwiększone | Zmniejszony | Zmiana liczby akcji netto |
|---|---|---|---|---|
| 80 (-4 vs poprzedni kw.) | 40 (-25 vs poprzedni kw.) | 199 (+17 vs poprzedni kw.) | 156 (+3 vs poprzedni kw.) | +28.2M |
Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.
| Instytucja | Wartość | Akcje | % z śledzonych 13F | Typ |
|---|---|---|---|---|
| Capital World Investors | $1 718 152 930 | 21 669 226 | 15,90% | Akcje |
| FMR LLC | $1 062 239 646 | 13 396 893 | 9,83% | Akcje |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $623 182 054 | 7 859 529 | 5,77% | Akcje |
| VANGUARD CAPITAL MANAGEMENT LLC | $571 799 597 | 7 211 497 | 5,29% | Akcje |
| WELLINGTON MANAGEMENT GROUP LLP | $558 240 214 | 7 040 487 | 5,17% | Akcje |
| TWO SIGMA INVESTMENTS, LP | $495 748 197 | 6 252 342 | 4,59% | Akcje |
| STATE STREET CORP | $343 710 098 | 4 334 848 | 3,18% | Akcje |
| GEODE CAPITAL MANAGEMENT, LLC | $260 920 005 | 3 157 327 | 2,41% | Akcje |
| TWO SIGMA ADVISERS, LP | $241 452 501 | 3 052 111 | 2,23% | Akcje |
| Artisan Partners Limited Partnership | $209 327 536 | 2 640 024 | 1,94% | Akcje |
| Tweedy, Browne Co LLC | $180 805 859 | 2 280 311 | 1,67% | Akcje |
| Deep Track Capital, LP | $174 438 000 | 2 200 000 | 1,61% | Akcje |
| BAKER BROS. ADVISORS LP | $162 364 274 | 2 047 727 | 1,50% | Akcje |
| DEERFIELD MANAGEMENT COMPANY, L.P. | $156 967 955 | 1 979 669 | 1,45% | Akcje |
| AMERICAN CENTURY COMPANIES INC | $154 383 816 | 1 947 076 | 1,43% | Akcje |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $127 260 529 | 1 605 001 | 1,18% | Akcje |
| Pictet Asset Management Holding SA | $126 981 913 | 1 596 998 | 1,18% | Akcje |
| BARCLAYS PLC | $125 150 305 | 1 578 387 | 1,16% | Akcje |
| GOLDMAN SACHS GROUP INC | $117 215 755 | 1 478 317 | 1,08% | Akcje |
| Polar Capital Holdings Plc | $115 289 325 | 1 454 021 | 1,07% | Akcje |
| Alyeska Investment Group, L.P. | $112 426 560 | 1 417 916 | 1,04% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $103 108 716 | 1 300 400 | 0,95% | Opcja kupna |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $103 108 000 | 1 300 392 | 0,95% | Akcje |
| VANGUARD FIDUCIARY TRUST CO | $84 114 400 | 1 060 845 | 0,78% | Akcje |
| GROUPAMA ASSET MANAGMENT | $75 195 315 | 937 083 | 0,70% | Akcje |
| Capital International Investors | $65 316 248 | 823 764 | 0,60% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $65 184 309 | 822 100 | 0,60% | Opcja sprzedaży |
| Davern Capital Partners, LP | $63 329 637 | 798 709 | 0,59% | Akcje |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | $62 422 083 | 787 263 | 0,58% | Akcje |
| Connor, Clark & Lunn Investment Management Ltd. | $54 253 072 | 684 236 | 0,50% | Akcje |
| Eversept Partners, LP | $52 702 794 | 664 684 | 0,49% | Akcje |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | $51 970 948 | 655 454 | 0,48% | Akcje |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $51 370 722 | 647 884 | 0,48% | Akcje |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $50 113 500 | 632 028 | 0,46% | Akcje |
| Caption Management, LLC | $49 952 700 | 630 000 | 0,46% | Opcja kupna |
| NEUBERGER BERMAN GROUP LLC | $46 951 653 | 592 151 | 0,43% | Akcje |
| EVENTIDE ASSET MANAGEMENT, LLC | $45 591 750 | 575 000 | 0,42% | Akcje |
| PERCEPTIVE ADVISORS LLC | $44 878 140 | 566 000 | 0,42% | Akcje |
| RENAISSANCE TECHNOLOGIES LLC | $44 355 936 | 559 414 | 0,41% | Akcje |
| JANE STREET GROUP, LLC | $44 045 595 | 555 500 | 0,41% | Opcja kupna |
| JANE STREET GROUP, LLC | $43 070 328 | 543 200 | 0,40% | Opcja sprzedaży |
| TEACHER RETIREMENT SYSTEM OF TEXAS | $41 414 514 | 522 317 | 0,38% | Akcje |
| BOONE CAPITAL MANAGEMENT LLC | $41 228 976 | 519 977 | 0,38% | Akcje |
| NEW YORK STATE COMMON RETIREMENT FUND | $39 648 965 | 500 050 | 0,37% | Akcje |
| BNP PARIBAS FINANCIAL MARKETS | $36 049 119 | 454 649 | 0,33% | Akcje |
| Candriam S.C.A. | $35 251 607 | 445 019 | 0,33% | Akcje |
| FIRST TRUST ADVISORS LP | $33 872 360 | 427 197 | 0,31% | Akcje |
| PINNACLE ASSOCIATES LTD | $33 282 136 | 419 752 | 0,31% | Akcje |
| BANK OF AMERICA CORP /DE/ | $32 643 138 | 411 693 | 0,30% | Akcje |
| NOMURA HOLDINGS INC | $31 889 804 | 402 192 | 0,30% | Akcje |
| Ikarian Capital, LLC | $31 716 000 | 400 000 | 0,29% | Opcja kupna |
| CITADEL ADVISORS LLC | $30 645 585 | 386 500 | 0,28% | Opcja sprzedaży |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $28 771 090 | 362 859 | 0,27% | Akcje |
| BlackRock, Inc. | $28 184 582 | 355 462 | 0,26% | Akcje |
| Caption Management, LLC | $27 426 411 | 345 900 | 0,25% | Opcja sprzedaży |
| TD Asset Management Inc | $27 002 051 | 340 548 | 0,25% | Akcje |
| Freestone Grove Partners LP | $26 955 983 | 339 967 | 0,25% | Akcje |
| AXA Investment Managers S.A. | $26 590 024 | 406 451 | 0,25% | Akcje |
| Qube Research & Technologies Ltd | $26 479 054 | 333 952 | 0,25% | Akcje |
| Capital Research Global Investors | $26 319 205 | 331 936 | 0,24% | Akcje |
| CAPITAL FUND MANAGEMENT S.A. | $26 130 336 | 329 554 | 0,24% | Akcje |
| ALLIANCEBERNSTEIN L.P. | $25 564 391 | 340 450 | 0,24% | Akcje |
| Carmignac Gestion | $25 452 090 | 321 000 | 0,24% | Akcje |
| Privium Fund Management B.V. | $25 366 774 | 319 924 | 0,23% | Akcje |
| Swiss National Bank | $24 976 350 | 315 000 | 0,23% | Akcje |
| ARK Investment Management LLC | $23 848 064 | 300 770 | 0,22% | Akcje |
| Integral Health Asset Management, LLC | $23 787 000 | 300 000 | 0,22% | Opcja kupna |
| Ikarian Capital, LLC | $23 787 000 | 300 000 | 0,22% | Opcja sprzedaży |
| MILLENNIUM MANAGEMENT LLC | $22 904 661 | 288 872 | 0,21% | Akcje |
| DAVENPORT & Co LLC | $22 515 188 | 283 960 | 0,21% | Akcje |
| Aberdeen Group plc | $21 995 046 | 277 400 | 0,20% | Akcje |
| California Public Employees Retirement System | $21 475 141 | 270 843 | 0,20% | Akcje |
| TimesSquare Capital Management, LLC | $20 700 361 | 275 674 | 0,19% | Akcje |
| MILLENNIUM MANAGEMENT LLC | $20 417 175 | 257 500 | 0,19% | Opcja kupna |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | $19 918 837 | 251 215 | 0,18% | Akcje |
| CITADEL ADVISORS LLC | $18 709 189 | 235 959 | 0,17% | Akcje |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $18 514 136 | 233 499 | 0,17% | Akcje |
| CITADEL ADVISORS LLC | $18 434 925 | 232 500 | 0,17% | Opcja kupna |
| Orion Investment Co | $17 470 362 | 220 335 | 0,16% | Akcje |
| Life Cycle Investment Partners Ltd | $17 435 554 | 219 896 | 0,16% | Akcje |
| ALGERT GLOBAL LLC | $16 401 374 | 206 853 | 0,15% | Akcje |
| Corient Private Wealth LP | $15 603 561 | 196 791 | 0,14% | Akcje |
| Eagle Health Investments LP | $15 428 010 | 194 577 | 0,14% | Akcje |
| SECTOR GAMMA AS | $15 022 918 | 189 468 | 0,14% | Akcje |
| Polymer Capital Management (HK) LTD | $14 105 453 | 177 897 | 0,13% | Akcje |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $13 252 259 | 176 485 | 0,12% | Akcje |
| ADAR1 Capital Management, LLC | $13 184 817 | 166 286 | 0,12% | Akcje |
| RHUMBLINE ADVISERS | $13 075 750 | 164 911 | 0,12% | Akcje |
| Sicart Associates LLC | $12 741 427 | 160 694 | 0,12% | Akcje |
| VANGUARD ASSET MANAGEMENT, Ltd | $12 296 928 | 155 088 | 0,11% | Akcje |
| CSS LLC/IL | $12 074 995 | 152 289 | 0,11% | Akcje |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | $11 996 656 | 151 301 | 0,11% | Akcje |
| CITIGROUP INC | $11 996 577 | 151 300 | 0,11% | Opcja kupna |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $11 893 500 | 150 000 | 0,11% | Akcje |
| Focus Partners Wealth | $11 728 366 | 147 917 | 0,11% | Akcje |
| Hudson Bay Capital Management LP | $11 497 050 | 145 000 | 0,11% | Akcje |
| Artia Global Partners LP | $11 447 573 | 144 376 | 0,11% | Akcje |
| Sonora Investment Management Group, LLC | $11 108 840 | 169 808 | 0,10% | Akcje |
| Fisher Asset Management, LLC | $10 877 317 | 137 184 | 0,10% | Akcje |
| Atle Fund Management AB | $10 873 116 | 137 131 | 0,10% | Akcje |
Insiderzy spółki 48 insiderów · 30 dyrektorzy generalni · 19 dyrektorzy
| Insider | Rola | Ostatnia aktywność | Posiadane akcje | Kupna 12m | Sprzedaże 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Brett P Monia | Chief Executive Officer | 26 czerwca 2026 M | 245 571 | 0 | 17 | $-42 648 430 |
| HOUGEN ELIZABETH L | EVP, Finance & CFO | 16 marca 2026 M | 82 660 | 0 | 6 | $-21 117 075 |
| Kleanthis G Xanthopoulos | President of Regulus | 3 grudnia 2007 A | — | 0 | 0 | $0 |
| Holly B. Kordasiewicz | EVP, Chief Development Officer | 7 lipca 2026 S | 22 096 | 0 | 4 | $-4 810 107 |
| BENNETT C FRANK | EVP, Chief Scientific Officer | 7 lipca 2026 J | 0 | 0 | 14 | $-19 804 154 |
| Eugene Schneider | EVP, Chf Clinical Develop Ofcr | 26 czerwca 2026 M | 77 114 | 0 | 6 | $-4 933 991 |
| Joseph Baroldi | EVP, Chief Business Officer | 26 czerwca 2026 M | 4 669 | 0 | 17 | $-6 405 525 |
| O'NEIL PATRICK R. | EVP CLO & General Counsel | 26 czerwca 2026 S | 61 470 | 0 | 16 | $-16 034 086 |
| Eric Swayze | EVP Research | 25 czerwca 2026 S | 21 759 | 0 | 14 | $-8 058 784 |
| Brian Birchler | EVP, Corp and Development Ops | 15 kwietnia 2026 M | 67 500 | 0 | 6 | $-3 556 351 |
| Kyle Jenne | EVP, Chf GL Pdt Str Ofcr | 15 kwietnia 2026 M | 23 713 | 0 | 4 | $-3 334 240 |
| Shannon L. Devers | EVP, Chief Human Resources Ofc | 2 kwietnia 2026 S | 16 348 | 0 | 15 | $-8 854 430 |
| Richard S Geary | EVP, Chief Development Officer | 6 listopada 2025 M | 59 657 | 0 | 13 | $-13 858 595 |
| Onaiza Cadoret-Manier | EVP,Chf GL Pdt Str & Oper Ofc | 2 lutego 2024 S | 35 788 | 0 | 0 | $0 |
| Stanley T Crooke | Exec Chairman of the Board | 26 stycznia 2021 S | 2 021 | 0 | 0 | $0 |
| Damien Mcdevitt | Chief Business Officer | 15 lipca 2019 M | 2 573 | 0 | 0 | $0 |
| Sarah Boyce | Chief Business Officer | 15 stycznia 2018 M | 8 931 | 0 | 0 | $0 |
| ECKER DAVID J | Vice President | 2 września 2008 M | 0 | 0 | 0 | $0 |
| Michael J Treble | Vice President, Pres of Ibis | 11 sierpnia 2008 M | 0 | 0 | 0 | $0 |
| Jeffrey M Jonas | Executive Vice President | 2 stycznia 2008 A | — | 0 | 0 | $0 |
| Mark K Wedel | VP & Chief Medical Officer | 6 lipca 2007 M | 6 603 | 0 | 0 | $0 |
| LEVIN ARTHUR A | Vice President | 25 kwietnia 2007 M | 1 674 | 0 | 0 | $0 |
| BROWN RICHARD K | Vice President | 8 marca 2006 M | 2 348 | 0 | 0 | $0 |
| MCNEIL JOHN A | Vice President | 3 stycznia 2005 A | — | 0 | 0 | $0 |
| LOWENSTAM PATRICIA | Vice President | 3 stycznia 2005 A | 603 | 0 | 0 | $0 |
| STEIN ARON | Vice President | 1 lipca 2004 J | 1 536 | 0 | 0 | $0 |
| Hans A De Haan | VP, Drug Development | 27 kwietnia 2004 S | 0 | 0 | 0 | $0 |
| LUNDSTEDT KAREN S | Vice President | 10 marca 2004 M | 5 407 | 0 | 0 | $0 |
| COLE DOUGLAS L | Vice President | 9 marca 2004 M | 9 616 | 0 | 0 | $0 |
| HOLMLUND JON T | Vice President | 1 lipca 2003 J | 983 | 0 | 0 | $0 |
| Michael R Hayden | Dyrektor | 31 lipca 2026 P | 24 000 | 2 | 0 | $1 058 700 |
| Peter N Reikes | Dyrektor | 15 lipca 2026 A | 14 222 | 0 | 0 | $0 |
| Ludwig Hantson | Dyrektor | 15 lipca 2026 A | — | 0 | 0 | $0 |
| Joan E Herman | Dyrektor | 15 lipca 2026 M | 51 306 | 0 | 2 | $-3 173 720 |
| BERTHELSEN SPENCER R | Dyrektor | 15 lipca 2026 M | 161 233 | 0 | 2 | $-1 193 280 |
| Allene M. Diaz | Dyrektor | 7 lipca 2026 M | 3 811 | 0 | 5 | $-5 278 717 |
| Michael J. Yang | Dyrektor | 1 lipca 2026 A | 7 940 | 0 | 0 | $0 |
| Joseph Loscalzo | Dyrektor | 1 lipca 2026 A | 36 330 | 0 | 6 | $-8 047 872 |
| Joseph Klein III | Dyrektor | 1 lipca 2026 A | 11 014 | 0 | 14 | $-9 356 036 |
| Lynne B Parshall | Dyrektor | 15 kwietnia 2026 S | 51 344 | 0 | 6 | $-2 171 964 |
| Joseph H Wender | Dyrektor | 1 grudnia 2025 S | 36 035 | 0 | 13 | $-8 660 283 |
| MUTO FREDERICK T | Dyrektor | 15 lipca 2022 M | 59 597 | 0 | 0 | $0 |
| Breaux Castleman | Dyrektor | 1 lipca 2020 A | 19 183 | 0 | 0 | $0 |
| REED JOHN C | Dyrektor | 6 września 2012 M | 0 | 0 | 0 | $0 |
| Richard D Dimarchi | Dyrektor | 1 lipca 2010 A | — | 0 | 0 | $0 |
| GARIELI CHRISTOPHER | Dyrektor | 1 lipca 2005 A | 155 431 | 0 | 0 | $0 |
| SKALETSKY MARK B | Dyrektor | 1 lipca 2004 A | — | 0 | 0 | $0 |
| ISIS PHARMACEUTICALS INC | Posiadacz 10% | 10 października 2020 P | 98 322 397 | 0 | 0 | $0 |
Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S
Aktywiści i właściciele 5%+ 5 akcji
Inwestorzy, którzy złożyli SEC Schedule 13D — posiadanie beneficjentów powyżej 5% z zamiarem wpływania na emitenta (udziały aktywistów, kampanie zarządu, M&A). Każdy wiersz pokazuje najnowszy znany stan pozycji tego zgłaszającego.
| Zgłaszający | Złożono | Udział | Status | Cel | Zgłoszenie |
|---|---|---|---|---|---|
| Ionis Pharmaceuticals, Inc. (“Ionis”) ×8 zgłoszenia | 13 października 2020 | — | Pierwotne zgłoszenie | — | SEC |
| Isis Pharmaceuticals, Inc. (“ Isis ”) | 31 lipca 2015 | — | Pierwotne zgłoszenie | — | SEC |
| Isis Pharmaceuticals, Inc. (“Isis”), Stanley T. Crooke (“Crooke”), B. Lynne Parshall (“Parshall”) ×2 zgłoszenia | 6 listopada 2014 | — | Pierwotne zgłoszenie | — | SEC |
| Genzyme Corporation | 15 stycznia 2008 | — | Pierwotne zgłoszenie | Inwestycja pasywna | SEC |
| Niezgłoszona osoba raportująca | 12 kwietnia 2001 | — | Pierwotne zgłoszenie | Inwestycja pasywna | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Posiadanie ETF-ów Posiadane przez 85 funduszy ETF
Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.
| Fundusz | Waga | Jednostki | Na dzień | Źródło |
|---|---|---|---|---|
| ARKG · ARK ETF Trust | 1,74% | 288 230 NS | 30 kwietnia 2026 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 1,72% | 201 598 NS | 30 kwietnia 2026 | N-PORT |
| BBP · ETFis Series Trust I | 1,48% | 11 708 NS | 30 kwietnia 2026 | N-PORT |
| GDOC · Goldman Sachs ETF Trust | 1,37% | 3 614 NS | 31 maja 2026 | N-PORT |
| CGMM · Capital Group Equity ETF Trust I | 1,14% | 414 653 NS | 31 maja 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,94% | 64 911 NS | 30 kwietnia 2026 | N-PORT |
| NUSC · Nushares ETF Trust | 0,87% | 150 398 NS | 30 kwietnia 2026 | N-PORT |
| TAX · EA Series Trust | 0,87% | 2 885 NS | 29 maja 2026 | N-PORT |
| JDOC · J.P. Morgan Exchange-Traded Fund Tr… | 0,84% | 1 257 NS | 30 kwietnia 2026 | N-PORT |
| COPY · RBB Fund Trust | 0,84% | 37 653 NS | 31 maja 2026 | N-PORT |
| HRTS · Tema ETF Trust | 0,83% | 5 599 NS | 31 maja 2026 | N-PORT |
| IBB · iShares Trust | 0,68% | 1 189 984 SH | 8 sierpnia 2026 | Dziennie |
| FFND · Northern Lights Fund Trust II | 0,67% | 9 000 NS | 31 maja 2026 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,64% | 8 994 SH | 8 sierpnia 2026 | Dziennie |
| BIB · ProShares Trust | 0,63% | 6 109 NS | 31 maja 2026 | N-PORT |
| MEDI · Harbor ETF Trust | 0,58% | 2 153 NS | 30 kwietnia 2026 | N-PORT |
| FDMO · FIDELITY COVINGTON TRUST | 0,53% | 60 169 NS | 30 kwietnia 2026 | N-PORT |
| FNY · First Trust Exchange-Traded AlphaDE… | 0,53% | 36 525 NS | 30 kwietnia 2026 | N-PORT |
| OASC · Unified Series Trust | 0,47% | 5 182 NS | 31 maja 2026 | N-PORT |
| QQQJ · Invesco Exchange-Traded Fund Trust … | 0,45% | 94 260 SH | 8 sierpnia 2026 | Dziennie |
| CGGR · Capital Group Growth ETF | 0,36% | 1 150 284 NS | 31 maja 2026 | N-PORT |
| VBK · VANGUARD INDEX FUNDS | 0,34% | 2 078 639 SH | 8 sierpnia 2026 | Dziennie |
| SMMV · iShares Trust | 0,32% | 17 089 SH | 8 sierpnia 2026 | Dziennie |
| BKMC · BNY Mellon ETF Trust | 0,30% | 25 160 NS | 30 kwietnia 2026 | N-PORT |
| ISCG · iShares Trust | 0,28% | 51 765 SH | 8 sierpnia 2026 | Dziennie |
| SCHA · SCHWAB STRATEGIC TRUST | 0,26% | 778 644 NS | 31 maja 2026 | N-PORT |
| IWP · iShares Trust | 0,24% | 895 755 SH | 8 sierpnia 2026 | Dziennie |
| SCHM · SCHWAB STRATEGIC TRUST | 0,23% | 438 447 NS | 31 maja 2026 | N-PORT |
| FSMD · FIDELITY COVINGTON TRUST | 0,23% | 71 810 NS | 30 kwietnia 2026 | N-PORT |
| BBMC · J.P. Morgan Exchange-Traded Fund Tr… | 0,22% | 60 227 NS | 30 kwietnia 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,22% | 110 695 SH | 8 sierpnia 2026 | Dziennie |
| JMOM · J.P. Morgan Exchange-Traded Fund Tr… | 0,21% | 62 392 NS | 30 kwietnia 2026 | N-PORT |
| FFLG · FIDELITY COVINGTON TRUST | 0,21% | 16 403 NS | 30 kwietnia 2026 | N-PORT |
| FNX · First Trust Exchange-Traded AlphaDE… | 0,20% | 36 263 NS | 30 kwietnia 2026 | N-PORT |
| VFMO · VANGUARD WELLINGTON FUND | 0,20% | 50 927 SH | 8 sierpnia 2026 | Dziennie |
| FHLC · FIDELITY COVINGTON TRUST | 0,19% | 70 978 NS | 30 kwietnia 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,18% | 471 609 SH | 8 sierpnia 2026 | Dziennie |
| SMLF · iShares Trust | 0,17% | 133 297 SH | 8 sierpnia 2026 | Dziennie |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,16% | 10 044 NS | 30 kwietnia 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,15% | 1 895 610 SH | 8 sierpnia 2026 | Dziennie |
| VB · VANGUARD INDEX FUNDS | 0,15% | 3 600 281 SH | 8 sierpnia 2026 | Dziennie |
| ESML · iShares Trust | 0,15% | 78 764 SH | 8 sierpnia 2026 | Dziennie |
| IYH · iShares Trust | 0,15% | 98 412 SH | 8 sierpnia 2026 | Dziennie |
| NBCR · Neuberger Berman ETF Trust | 0,14% | 16 581 NS | 31 maja 2026 | N-PORT |
| ISCB · iShares Trust | 0,14% | 7 328 SH | 8 sierpnia 2026 | Dziennie |
| AVIE · AMERICAN CENTURY ETF TRUST | 0,13% | 176 NS | 31 maja 2026 | N-PORT |
| SMMD · iShares Trust | 0,12% | 81 988 SH | 8 sierpnia 2026 | Dziennie |
| WSML · iShares Trust | 0,08% | 9 548 SH | 8 sierpnia 2026 | Dziennie |
| LRND · New York Life Investments ETF Trust | 0,07% | 2 788 NS | 30 kwietnia 2026 | N-PORT |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,07% | 9 928 SH | 8 sierpnia 2026 | Dziennie |